Atrion Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
131,993.00
140,762.00
145,733.00
143,487.00
146,595.00
152,448
Cost of Goods Sold (COGS) incl. D&A
68,931.00
72,244.00
74,752.00
75,857.00
75,841.00
80,670
Gross Income
63,062.00
68,518.00
70,981.00
67,630.00
70,754.00
71,778
SG&A Expense
25,118.00
27,701.00
28,471.00
28,504.00
29,480.00
30,071
EBIT
37,944.00
40,817.00
42,510.00
-
41,274.00
41,707
Unusual Expense
-
-
2,400.00
-
-
-
Non Operating Income/Expense
8.00
13.00
11.00
308.00
1.00
1,338
Pretax Income
39,265.00
42,021.00
40,870.00
39,266.00
42,340.00
42,036
Income Tax
12,683.00
14,213.00
11,945.00
11,685.00
5,747.00
7,781
Consolidated Net Income
26,582.00
27,808.00
28,925.00
27,581.00
36,593.00
34,255
Net Income
26,582.00
27,808.00
28,925.00
27,581.00
36,593.00
34,255
Net Income After Extraordinaries
26,582.00
27,808.00
28,925.00
27,581.00
36,593.00
34,255
Net Income Available to Common
26,582.00
27,808.00
28,925.00
27,581.00
36,593.00
34,255
EPS (Basic)
13.18
14.08
15.47
14.85
19.71
18.44
Basic Shares Outstanding
2,010.00
1,958.00
1,846.00
1,824.00
1,846.00
1,853
EPS (Diluted)
13.18
14.08
15.47
14.85
19.71
18.44
Diluted Shares Outstanding
2,017.00
1,975.00
1,870.00
1,857.00
1,857.00
1,858
EBITDA
46,536.00
49,540.00
51,333.00
48,079.00
49,951.00
50,829
Non-Operating Interest Income
1,313.00
1,191.00
771.00
448.00
1,065.00
1,667

About Atrion

View Profile
Address
One Allentown Parkway
Allen Texas 75002
United States
Employees -
Website http://www.atrioncorp.com
Updated 07/08/2019
Atrion Corp. engages in the manufacture and development of products for medical applications. Its products include cardiac surgery vacuum relief valves, Retract-O-Tape silicone vessel loops, for retraction and occluding vessels in minimally invasive surgical procedures, and CleanCut rotating aortic punch. The company specializes in the fluid delivery, as well as ophthalmic and cardiovascular devices.